Premium
Review article: tegaserod — the global experience
Author(s) -
Chey W. D.
Publication year - 2004
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2004.02181.x
Subject(s) - tegaserod , irritable bowel syndrome , medicine , constipation , lubiprostone , western hemisphere , intensive care medicine , chronic constipation , international economics , economics
Summary Studies from the Western hemisphere have established the efficacy and safety of tegaserod in women with irritable bowel syndrome and constipation. This review summarizes the results of recent studies from around the world that confirm the efficacy and safety of tegaserod, and expand our understanding of the role of this drug in the treatment of patients with irritable bowel syndrome.